Literature DB >> 1458597

Alkaline phosphatase isoenzyme patterns in malignant disease.

V O Van Hoof1, A T Van Oosterom, L G Lepoutre, M E De Broe.   

Abstract

Early treatment of patients with malignant disease and liver or bone metastasis may increase their survival time. We have used the activity patterns of liver and bone isoenzymes of alkaline phosphatase (ALP), separated by agarose gel electrophoresis, to detect early metastasis. We studied ALP isoenzyme patterns in a background population of 101 patients with no evidence of any disease that might influence this pattern; a healthy reference population (n = 330); and the following three groups of patients: 143 with malignant disease, 47 with nonmalignant liver disease, and 22 with nonmalignant bone disease. Cutoff and predictive values of liver ALP, high-molecular-mass (high-M(r)) ALP, and bone ALP were established for detecting liver and bone metastasis. The positive predictive value of liver and high-M(r) ALP was higher than that of total ALP in detecting liver metastasis, but liver and high-M(r) ALP did not enable us to differentiate between malignant and nonmalignant liver disease. Total ALP activity was of slightly more value than liver and high-M(r) ALP in enabling us to rule out liver metastasis. From bone ALP activity we could not distinguish between nonmalignant bone disease and bone metastasis. The negative predictive value of bone ALP in the diagnosis of bone metastasis was low, but its positive predictive value was high and superior to that of total ALP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458597

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Lectin affinity electrophoresis of serum alkaline phosphatase in metastasized breast cancer.

Authors:  Thierry Le Bricon; Cécile Gay-Bellile; Paul Cottu; Mourad Benlakehal; Hélène Guillon; Pascal Houzé
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.

Authors:  Jae Ho Chung; Moo Suk Park; Young Sam Kim; Joon Chang; Joo Hang Kim; Sung Kyu Kim; Se Kyu Kim
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

3.  Biochemical diagnosis of liver disease.

Authors:  P L Wolf
Journal:  Indian J Clin Biochem       Date:  1999-01

4.  Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis.

Authors:  G Ramaswamy; V R Rao; L Krishnamoorthy; G Ramesh; R Gomathy; D Renukadevi
Journal:  Indian J Clin Biochem       Date:  2000-07

5.  Studies of biochemical parameters in breast cancer with and without metastasis.

Authors:  Sandhya Mishra; D C Sharma; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2004-01

6.  Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India.

Authors:  A K Singh; A Pandey; M Tewari; R Kumar; A Sharma; K A Singh; H P Pandey; H S Shukla
Journal:  3 Biotech       Date:  2013-01-06       Impact factor: 2.406

7.  Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer.

Authors:  Bo Chen; Danian Dai; Hailin Tang; Xi Chen; Xiaohong Ai; Xiaojia Huang; Weidong Wei; Xiaoming Xie
Journal:  J Cancer       Date:  2016-11-25       Impact factor: 4.207

8.  Serum alkaline phosphatase in oral squamous cell carcinoma and its association with clinicopathological characteristics.

Authors:  Swetha Acharya; Jyoti Kale; Pragati Rai; Venkatesh Anehosur; Kaveri Hallikeri
Journal:  South Asian J Cancer       Date:  2017 Jul-Sep

9.  Machine Learning in Prediction of Bladder Cancer on Clinical Laboratory Data.

Authors:  I-Jung Tsai; Wen-Chi Shen; Chia-Ling Lee; Horng-Dar Wang; Ching-Yu Lin
Journal:  Diagnostics (Basel)       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.